In Refractory IBD, Combination Tx Appears Safe, Effective :

In the treatment of IBD, combinations of biologics or a biologic and tofacitinib appeared to be generally safe and effective, according to a new systematic review and meta-analysis.

Related Keywords

United States , American , Davidt Rubin , Ali Osman , Crohn Colitis Foundation , Pcrohn Colitis Congress , Washington University School Of Medicine , American Gastroenterological Association , Colitis Foundation , American Gastroenterological , Washington University School , Inflammatory Bowel Disease Center , Inflammatory Bowel Disease Ibd , Biologic Therapy , Iologics , Meta Analysis , Adverse Effects , Side Effects , Colitis , Refractory , Remission , Crohn Amp 039s Disease , Crohn Disease , Egional Enteritis Crohn S , Patient Safety , Ulcerative Colitis , Lcerative Colitis Uc , C Ulcerative Colitis , Grant , Targeted Therapy , Targeted Cancer Therapy , Washington ,